Compare AIXI & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIXI | TNON |
|---|---|---|
| Founded | 2001 | 2012 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9M | 8.9M |
| IPO Year | 2023 | 2022 |
| Metric | AIXI | TNON |
|---|---|---|
| Price | $0.65 | $1.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 189.8K | 125.7K |
| Earning Date | 12-26-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $70,314,315.00 | $3,233,000.00 |
| Revenue This Year | $26.84 | $19.56 |
| Revenue Next Year | N/A | $71.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.84 | N/A |
| 52 Week Low | $0.60 | $0.85 |
| 52 Week High | $6.65 | $5.85 |
| Indicator | AIXI | TNON |
|---|---|---|
| Relative Strength Index (RSI) | 36.75 | 45.73 |
| Support Level | $0.64 | $1.10 |
| Resistance Level | $0.71 | $1.15 |
| Average True Range (ATR) | 0.08 | 0.05 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 19.98 | 62.50 |
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.